Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common shares	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income / (Loss)	Accumulated Deficit
Balance, beginning of period (in shares) at Jun. 30, 2023		18,280,000
Balance, beginning of period at Jun. 30, 2023	$ 149,964	$ 2	$ (3,682)	$ 204,734	$ (6,312)	$ (44,778)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,425					7,425
Foreign currency translation adjustments	(701)				(701)
Changes in fair value of cash flow hedges	$ (194)				(194)
Purchase of treasury shares (in shares)	(134,524)	(134,000)
Purchase of treasury shares	$ (2,044)		(2,044)
Provision for common stock warrants	287			287
Issuance of common shares (in shares)		23,000
Issuance of common shares	5			5
Share-based compensation expense	1,297			1,297
Balance, end of period (in shares) at Sep. 30, 2023		18,169,000
Balance, end of period at Sep. 30, 2023	$ 156,039	$ 2	(5,726)	206,323	(7,207)	(37,353)
Balance, beginning of period (in shares) at Jun. 30, 2024	17,017,476	17,017,000
Balance, beginning of period at Jun. 30, 2024	$ 165,799	$ 2	(25,367)	210,200	(7,913)	(11,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,531					7,531
Foreign currency translation adjustments	1,388				1,388
Changes in fair value of cash flow hedges	$ 379				379
Purchase of treasury shares (in shares)	(282,129)	(282,000)
Purchase of treasury shares	$ (4,678)		(4,678)
Provision for common stock warrants	0			0
Issuance of common shares (in shares)		30,000
Issuance of common shares	382			382
Share-based compensation expense	$ 290			290
Balance, end of period (in shares) at Sep. 30, 2024	16,765,381	16,765,000
Balance, end of period at Sep. 30, 2024	$ 171,091	$ 2	$ (30,045)	$ 210,872	$ (6,146)	$ (3,592)